{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:10:02Z","timestamp":1788775802177,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/01yc7t268","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The differential diagnosis of classic Hodgkin lymphoma (CHL) versus anaplastic large cell lymphoma (ALCL) and other T-cell lymphomas (TCL) with Hodgkin-like features remains challenging in some cases, and may require TCR molecular testing with prolonged turnaround time. The limited literature has previously described PRAME (Preferentially Expressed Antigen in Melanoma) overexpression in Hodgkin cells and its absence in cutaneous T-cell lymphomas. The aim of this study was to examine the staining pattern of PRAME in CHL compared to the pattern in non-cutaneous ALCL and TCL. Methods: Twenty-four cases of CHL, 21 cases of ALK-negative ALCL, nine cases of ALK-positive ALCL and 11 cases of other TCL were stained for PRAME. Results: PRAME showed strong and diffuse (3+) expression in 80% of CHL cases while, in contrast, 0% of ALK-negative ALCL showed 3+ staining and 11% of ALK-positive ALCL showed 3+ staining. Non-ALCL TCL showed only 0 or 1+ staining. Conclusions: PRAME may be another helpful stain in the workup of CHL and its morphologic mimics.<\/jats:p>","DOI":"10.3390\/cancers18172875","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:23:37Z","timestamp":1788773017000},"page":"2875","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of PRAME Immunohistochemistry in Distinguishing Classic Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma and T-Cell Lymphoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Xin","family":"Duan","sequence":"first","affiliation":[{"name":"Department of Pathology and Immunology, Washington University School of Medicine, 660\u00a0South Euclid Ave, Campus Box 8118, St. Louis, MO 63110, USA"},{"name":"Barnes-Jewish Hospital, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4587-0647","authenticated-orcid":false,"given":"Katherine N.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Washington University School of Medicine, 660\u00a0South Euclid Ave, Campus Box 8118, St. Louis, MO 63110, USA"},{"name":"Barnes-Jewish Hospital, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-8424","authenticated-orcid":false,"given":"Anne L.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Washington University School of Medicine, 660\u00a0South Euclid Ave, Campus Box 8118, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/00000478-199712000-00004","article-title":"Anaplastic large cell lymphoma: A distinct molecular pathologic entity: A reappraisal with special reference to p80(NPM\/ALK) expression","volume":"21","author":"Nakamura","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin\u2019s lymphoma: Report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"bcr2015211159","DOI":"10.1136\/bcr-2015-211159","article-title":"PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement","volume":"2015","author":"Ong","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_5","first-page":"1047","article-title":"Hodgkin\u2019s disease and CD30-positive anaplastic large cell lymphomas\u2014A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study","volume":"137","author":"Leoncini","year":"1990","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2017-12-819987","article-title":"An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"131","author":"Wang","year":"2018","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classical Hodgkin\u2019s lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bosch-Schips, J., Granai, M., Quintanilla-Martinez, L., and Fend, F. (2022). The Grey Zones of Classic Hodgkin Lymphoma. Cancers, 14.","DOI":"10.3390\/cancers14030742"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12970-020-00389-y","article-title":"The effects of alpha lipoic acid on muscle strength recovery after a single and a short-term chronic supplementation\u2014A study in healthy well-trained individuals after intensive resistance and endurance training","volume":"17","author":"Isenmann","year":"2020","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1476-4598-9-226","article-title":"Leucine-rich repeat protein PRAME: Expression, potential functions and clinical implications for leukaemia","volume":"9","author":"Wadelin","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000381533","article-title":"PRAME Expression and Its Clinical Relevance in Hodgkin\u2019s Lymphoma","volume":"134","author":"Ercolak","year":"2015","journal-title":"Acta Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/PAS.0000000000001944","article-title":"PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors","volume":"46","author":"Kaczorowski","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.64.15.36","article-title":"PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma","volume":"64","author":"Gelmi","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1182\/blood-2025-3306","article-title":"Expression of the cancer testis antigen PRAME is associated with response to immune checkpoint inhibitor and rituximab priming in treatment-na\u00efve diffuse large B-cell lymphoma","volume":"146","author":"Manos","year":"2025","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood-2019-129730","article-title":"PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma","volume":"134","author":"Takata","year":"2019","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/dermatopathology9010002","article-title":"Lack of PRAME Expression in Cutaneous T-Cell Lymphomas","volume":"9","author":"Bui","year":"2021","journal-title":"Dermatopathology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PAS.0000000000001393","article-title":"Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1121\/1.1290516","article-title":"Localization of multiple sound sources with two microphones","volume":"108","author":"Liu","year":"2000","journal-title":"J. Acoust. Soc. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2040620716676256","article-title":"Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma","volume":"8","author":"Sethi","year":"2017","journal-title":"Ther. Adv. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.humpath.2021.05.008","article-title":"Syncytial variant of nodular sclerosis Hodgkin lymphoma: An under-emphasized variant","volume":"117","author":"Wang","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/1097-0142(19900301)65:5<1167::AID-CNCR2820650523>3.0.CO;2-V","article-title":"Syncytial variant of nodular sclerosing Hodgkin\u2019s disease. A new clinicopathologic entity","volume":"65","author":"Polliack","year":"1990","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/bloodadvances.2023010149","article-title":"Current clinical practices and challenges in molecular testing: A GOAL Consortium Hematopathology Working Group report","volume":"7","author":"Lee","year":"2023","journal-title":"Blood Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcp.10215","article-title":"Cancer\/testis-associated genes: Identification, expression profile, and putative function","volume":"194","author":"Zendman","year":"2003","journal-title":"J. Cell Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":"The gene expression signatures of melanoma progression","volume":"102","author":"Haqq","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1159\/000487353","article-title":"Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway","volume":"45","author":"Zhu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhang, X.R., Chien, P.N., Nam, S.Y., and Heo, C.Y. (2022). Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment. Cancers, 14.","DOI":"10.3390\/cancers14071650"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: Genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.leukres.2008.10.010","article-title":"Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene","volume":"33","author":"Gunn","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.leukres.2013.03.018","article-title":"The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus","volume":"37","author":"Mraz","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e145343","DOI":"10.1172\/JCI145343","article-title":"Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma","volume":"132","author":"Takata","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kewitz, S., and Staege, M.S. (2013). Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055897"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12185-014-1593-z","article-title":"Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy","volume":"100","author":"Mitsuhashi","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2563773","DOI":"10.1080\/19420862.2025.2563773","article-title":"Development of a PRAME pMHC targeted T cell engager for solid tumor therapy","volume":"17","author":"Skrzypczynska","year":"2025","journal-title":"mAbs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/bloodadvances.2022008304","article-title":"Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia","volume":"7","author":"Kirkey","year":"2023","journal-title":"Blood Adv."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2875\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:37:08Z","timestamp":1788773828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":37,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172875"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172875","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]}}}